Publication - Abstract
Jan 05, 2016
Harnessing RNAi-Based Nanomedicines for Therapeutic Gene Silencing in B-cell Malignancies
Despite progress in systemic small interfering RNA (siRNA) delivery to the liver and to solid tumors, systemic siRNA delivery to leukocytes remains challenging. The ability to silence gene expression in leukocytes has great potential for ...